Trial intelligence / Profile preview

Laser and Steroid Therapy for Facial Nerve Injury in Rats

NCT06185426Phase 1Active, not recruiting

Sponsor
Recep Tayyip Erdoğan University
Start
Jan 2021
Primary completion
Jun 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, randomised trial of methylprednisolone in facial nerve injury, sponsored by Recep Tayyip Erdoğan University. Primary endpoint: Electromyographic Analysis at 1 month. Started Jan 2021; status: active, not recruiting.

02

Drugs

methylprednisolone
03

Conditions

facial nerve injury

Beyond the preview

Go deeper on NCT06185426.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06185426.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call